WallStreetZenWallStreetZen

NYSE: CTLT
Catalent Inc Stock Ownership - Who owns Catalent?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Catalent Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Ricky HopsonPres. Clinical Dev Supply Div2023-01-23643$49.36
$31.74kSell
Manja BoermanPres. BioModalities Division2022-12-05780$51.70
$40.33kSell
Michael J. GrippoSVP Strategy Corp. Dev.2022-10-312,451$65.83
$161.35kSell
Christa KreuzburgDirector2022-10-27421$66.27
$27.90kSell
Thomas W. HawkeswoodPres. Pharma Prod Delivery Div2022-10-10930$77.46
$72.04kSell
Ricky HopsonPres. Clinical Dev Supply Div2022-08-312,216$89.59
$198.53kSell
Scott GuntherSVP Quality & Reg. Affairs2022-08-261,639$104.07
$170.57kSell
Michael A. RileyPres. Bio Product Delivery Div2022-08-262,491$104.07
$259.24kSell
Kay A. SchmidtSVP Enterprise Functions2022-08-251,321$103.04
$136.12kSell
Jonathan ArnoldSVP & Chief Commercial Ofcr2022-08-25384$103.04
$39.57kSell

1 of 5

CTLT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CTLT insiders and whales buy or sell their stock.

CTLT Shareholders

What type of owners hold Catalent Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackstone Healthcare Partners LLC22.23%40,030,960$2.59BInsider
Vanguard Group Inc10.88%19,588,103$1.27BInstitution
T Rowe Price Investment Management Inc9.21%16,578,946$1.07BInstitution
Capital World Investors7.67%13,817,203$893.28MInstitution
Blackrock Inc7.66%13,789,156$891.47MInstitution
Veritas Asset Management LLP6.20%11,169,815$722.13MInstitution
Peter Zippelius4.82%8,672,903$560.70MInsider
Janus Henderson Group PLC4.56%8,216,242$531.18MInstitution
Artisan Partners Limited Partnership4.35%7,842,308$507.01MInstitution
State Street Corp4.09%7,367,321$476.30MInstitution

1 of 3

CTLT vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CTLT78.76%21.24%Net SellingNet Selling
VTRS77.35%17.72%Net SellingNet Selling
TEVA50.52%0.80%Net SellingNet Selling
RDY9.86%0.00%
PRGO61.63%38.37%Net BuyingNet Buying
View Top Pharmaceutical Stocks

Catalent Stock Ownership FAQ

Who owns Catalent?

Catalent (NYSE: CTLT) is owned by 103.38% institutional shareholders, 27.88% Catalent insiders, and 0.00% retail investors. Blackstone Healthcare Partners LLC is the largest individual Catalent shareholder, owning 40.03M shares representing 22.23% of the company. Blackstone Healthcare Partners LLC's Catalent shares are currently valued at $2.51B.

If you're new to stock investing, here's how to buy Catalent stock.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.